Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.
24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men.
“Health Canada has approved Illuccix®, providing Canadian physicians with a new diagnostic tool” states André Gagnon, president of Isologic. “Illuccix® is available from Isologic, which supplies it to the entire Canadian territory to ensure that all patients have access to Illuccix®”.
The product is available in a cold kit or as a single dose.
Please follow the link for the entiere release